Concepedia

Publication | Open Access

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study

29

Citations

15

References

2021

Year

Abstract

Humoral immunity is stable after SARS-CoV-2 infection in MS, but is reduced by immunosuppressive DMT, particularly anti-CD20 monoclonal antibodies. This provides important evidence for advising pwMS as well as for planning and prioritizing vaccination.

References

YearCitations

Page 1